Brand: Horizon Pharmaceuticals

Empaa L 25/5mg (28 Tablet / Pack)

Empagliflozin/linagliptin 25/5mg for type 2 diabetes.

PKR 1260.00

You save: PKR 0

Quantity:

SKU: EMPAA_L_25/5MG_TAB_28S_NV

Category: Tablets & Capsules

Empaa L combines Empagliflozin 25mg (SGLT2 inhibitor) and Linagliptin 5mg (DPP-4 inhibitor) for type 2 diabetes. It improves glycaemic control and can reduce cardiovascular death when indicated.

Purpose

Type 2 diabetes with diet and exercise; reduction of cardiovascular death when empagliflozin is indicated.

Ingredients

Empagliflozin 25mg, Linagliptin 5mg

Warnings

Not for type 1 diabetes or DKA. DKA risk in acute illness. Prescription only.

Side Effects

Genital mycotic infections, UTI, nasopharyngitis. Rare: DKA, pancreatitis.

Storage Instructions

Store below 30°C. Keep in original pack. Protect from moisture.

Brand	Horizon Pharmaceuticals
Status	Active

Shop by Category